Novasep appoints two key executives

Novasep, producer of active molecules for the life science industry, has announced the appointments of two managers in what it describes as a drive to grow the group’s US presence and develop its Novasep Synthesis division.

Stephen F. Stefano becomes president and CEO of Novasep North American business, and Patrick A. Glaser becomes president and CEO of the Novasep Synthesis division, a new position created as a result of its ongoing global integration.

“Both Steve and Patrick will bring added quality, strength and experience to Novasep management,” said Roger-Marc Nicoud, the company’s president and CEO, in a statement. “Patrick, with his double European and US culture and his broad manufacturing and operational experience, will spearhead Novasep Synthesis’ drive for international success. The deep knowledge and wide connections of Steve within the pharmaceutical and biopharmaceutical industries will be of primary importance to help us establish key partnerships with our customers, and make strategic progress in the US.”

According to a statement from the company, both are expected to play an important role in its development plans over the next few years. The US will be a major source of growth for both Novasep Process and Novasep Synthesis divisions, while the group’s activity in synthetic molecule manufacture will remain globally its largest source of revenues.

For more information on the company visit www.novasep.com